FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review

Dilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F. Palm, Giuseppe Malleo, Ryan K. Schmocker, Raëf Abdallah, Changhoon Yoo, Walid L. Shaib, Marcel André Schneider, Elena Rangelova, Yoo Jin Choi, Hongbeom Kim, J. Bart Rose, Sameer Patel, Gregory C. Wilson, Sarah Maloney, Lea Timmermann, Klaus Sahora, Fabian Rössler, Víctor Lopez-LopezEmanuel Boyer, Laura Maggino, Thomas Malinka, Jeong Youp Park, Matthew H.G. Katz, Laura Prakash, Syed A. Ahmad, Scott Helton, Jin Young Jang, Sarah E. Hoffe, Roberto Salvia, Julien Taieb, Jin He, Pierre Alain Clavien, Ulrike Held, Kuno Lehmann

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review'. Together they form a unique fingerprint.

Medicine & Life Sciences